SEC Form 4 research
| Issuer | Gain Therapeutics, Inc. |
|---|---|
| Tickers | GANX |
| Reporting owners | 14 |
| Officers and directors | 6 |
| Last public filing | 2026-10-30 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-30 | 2026-10-29 | Weidner Jeanette | A | 130,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.